Walleye Trading
ROIV icon

Walleye Trading’s Roivant Sciences ROIV Stock Holding History

Walleye Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-700
Closed -$19.4K – 4383
2026
Q1 		$19.4K Sell
700
-60,200
-99% -$1.55M ﹤0.01% 3870
2025
Q4 		$1.32M Sell
60,900
-6,400
-10% -$126K ﹤0.01% 2176
2025
Q3 		$1.02M Buy
67,300
+23,200
+53% +$287K ﹤0.01% 2256
2025
Q2 		$497K Buy
44,100
+8,500
+24% +$92.1K ﹤0.01% 2657
2025
Q1 		$359K Hold
35,600
– – ﹤0.01% 2738
2024
Q4 		$421K Sell
35,600
-3,600
-9% -$42.6K ﹤0.01% 2738
2024
Q3 		$452K Buy
39,200
+4,200
+12% +$47.8K ﹤0.01% 2576
2024
Q2 		$370K Buy
+35,000
New +$384K ﹤0.01% 2726
2024
Q1 		– Sell
-300
Closed -$3.37K – 5248
2023
Q4 		$3.37K Buy
+300
New +$2.92K ﹤0.01% 4755

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Walleye Trading's ROIV Position: Q2 2026 in Review

Walleye Trading sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 3,420 shares — an estimated $94.7K sold.

Walleye Trading first reported a position in ROIV in Q4 2023 and held it in 2 quarters. The position peaked at $446K in Q4 2023. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Walleye Trading reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 3,420 Roivant Sciences shares in Q2 2026, an estimated $94.7K.
  • Walleye Trading first reported a position in Roivant Sciences in Q4 2023 and held it in 2 quarters.
  • Walleye Trading's Roivant Sciences position peaked at $446K in Q4 2023.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.